34
Participants
Start Date
April 30, 2012
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
placebo
Administered up to 8 weeks.
extended-release guanfacine (Intuniv)
1 mg tablets; flexible dosing up to 4 mg/day for up to 16 weeks.
Mount Sinai School of Medicine, New York
University of South Florida, Tampa
Yale Child Study Center, New Haven
Collaborators (1)
Icahn School of Medicine at Mount Sinai
OTHER
University of South Florida
OTHER
Shire
INDUSTRY
New York University
OTHER
Yale University
OTHER